Table 3.
Inclusion | Exclusion |
---|---|
Years 2000–2016 | Reviews |
Journal articles | Non-English language studies |
Cost-effectiveness/utility studies | Conference abstracts |
Studies in advanced, mortally ill patients (EOL period during which a person’s condition is actively deteriorating and when death is expected) | Study protocols |
Studies written from palliative care paradigm | BSC studies |
Studies in non-human or children | |
Broader palliative care studies | |
Broader health economic studies (without CE analyses) | |
Chronic/allergic/non-EOL diseases | |
First-line/primary treatments | |
Critical/intensive care studies | |
Studies about predictive testing/prevention/screening | |
Studies on developing/evaluating new interventions |
CE: cost-effectiveness; EOL: end of life; BSC: best supportive care.